文献速递急性肾损伤慢性肾脏病

儿童肿瘤患者的肾毒性与肾脏结局

Nephrotoxicity and kidney outcomes in pediatric oncology patients.
PubMed 文献 · Nephrol Dial Transplant · 2026-01-01

这项回顾性全国队列研究分析了2015至2021年在Princess Máxima中心治疗的1525例儿童癌症患者,37%发生急性肾损伤(AKI),环磷酰胺以外的异环磷酰胺、两性霉素B、阿昔洛韦和白消安是AKI的强独立危险因素;随访1年时13.6%出现慢性肾脏病(CKD),AKI是CKD最强预测因素,单次AKI风险增加2.6倍,多次AKI增加近16倍。

要点

  • 儿童癌症患者AKI累积发生率为37%。
  • 异环磷酰胺、两性霉素B、阿昔洛韦和白消安为AKI强独立危险因素。
  • 单次AKI使CKD风险增加2.6倍,多次AKI增加近16倍。

核心结论

  • AKI在儿童癌症患者中常见,且与CKD风险增加强相关;对接受肾毒性药物、有多次AKI发作史或肾切除术史的高危患者应提高认识,并实施全程监测策略以早期发现和干预。

研究设计与样本

  • 回顾性全国队列研究,纳入2015年至2021年在Princess Máxima中心治疗的1525例儿童癌症患者,采用KDIGO标准基于血清肌酐定义AKI,使用病因特异性风险回归模型评估危险因素对AKI发生和进展的影响,采用竞争风险模型(死亡为竞争事件)估计AKI累积发生率,采用逻辑回归评估危险因素对CKD(治疗结束后1年eGFR<90 ml/min/1.73 m²)的影响。

主要发现

  • 37%的患者发生AKI。
  • 竞争风险模型确定异环磷酰胺、两性霉素B、阿昔洛韦和白消安为首次AKI发作的强独立危险因素,年龄较大也与AKI风险增加相关。
  • 1年随访时(n=1159),13.6%存在CKD(eGFR<90 ml/min/1.73 m²),2.8%的eGFR<60。
  • 治疗期间发生的AKI是CKD最强预测因素:单次AKI发作使风险增加2.6倍,多次发作使风险增加近16倍。
  • 肾切除术也被确定为CKD的独立危险因素。

关键数值与推荐

  • AKI依据KDIGO标准基于血清肌酐分类。
  • CKD定义为癌症治疗结束后1年eGFR<90 ml/min/1.73 m²。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Acute kidney injury (AKI) is a serious complication during pediatric cancer treatment. Nephrotoxic medication may increase the risk of developing AKI, which may necessitate modifications to standard treatment and may also increase the risk of chronic kidney disease (CKD). This study investigates the incidence of AKI, the impact of nephrotoxic medications and the association between AKI and the development of CKD. METHODS: In this retrospective national cohort study, we analyzed 1525 pediatric cancer patients treated at the Princess Máxima Center between 2015 and 2021. AKI was classified using KDIGO criteria based on serum creatinine. The effect of nephrotoxic medications and other risk factors on AKI incidence and progression was assessed by using a cause specific hazard regression model. The cumulative incidence of AKI was estimated with a competing risk model with death as competing event. The effect of risk factors on CKD, defined as an eGFR <90 ml/min/1.73 m² 1 year after cancer treatment, was evaluated with a logistic regression. RESULTS: We included 1525 patients, 37% experienced AKI. A competing risk model identified treatment with ifosfamide, amphotericin B, acyclovir, and busulfan as strong, independent risk factors for a first episode of AKI. Older age was also associated with an increased risk of AKI.At 1-year follow-up (n = 1159), 13.6% had CKD (eGFR <90 ml/min/1.73 m²), and 2.8% had an eGFR <60. AKI (occurred during treatment) was the strongest predictor of CKD: a single AKI episode increased the risk 2.6-fold, while more episodes increased it nearly 16-fold. Nephrectomy was also identified as independent risk factors for CKD. CONCLUSION: Acute kidney injury (AKI) is common in children with cancer and is strongly associated with an increased risk of chronic kidney disease (CKD). Awareness is crucial for high-risk patients, particularly those receiving nephrotoxic medications, with a history of multiple AKI episodes or a prior nephrectomy. Comprehensive monitoring strategies should be implemented at diagnosis, during therapy, and during the post-treatment period to enable early detection and timely intervention, ultimately reducing the risk of AKI and its progression to CKD.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Raymakers-Janssen PAMA, Leitzinger N, van den Berg G, et al. Nephrotoxicity and kidney outcomes in pediatric oncology patients. Nephrol Dial Transplant. 2026. PMID: 40844823. doi:10.1093/ndt/gfaf169

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。